Address
250 Washington St., 2nd Floor, Boston, MA 02108
- This page, Drug Formulary Commission meeting, is offered by
- Drug Control Program
Public Meeting Notice
Public Meeting Notice Drug Formulary Commission meeting
Overview of Drug Formulary Commission meeting
In the Henry I. Bowditch Public Health Council Room, on the 2nd floor.
Relevant documents
- FDA Embeda Supplement Approval Letter (DOC)
- Joint Meeting of ALSDAC and DSaRM September 24, 2009 (DOC)
- Purdue Comments on FDA Announcement on REMS For Extended-Release And Long-Acting Opioid Analgesics (DOC)
- Purdue Post Market Press Release (DOC)
- Purdue OxyContin Postmarket Requirements and Commitments (No File Available)
- Embeda Reference List (Amended)
- Embeda Drug Monograph (Amended)
- OxyContin Reference List (amended)
- OxyContin Drug Monograph (Amended)
Agenda
Agenda
- ROUTINE ITEMS:
- Welcome and Opening Remarks
- Approval of the Minutes (Vote)
- COST ASSESSMENT
- Request for an Insurance Benefit Review from the Center for Health Information and Analysis (CHIA) (Vote)
- EVALUATION AND REVIEW OF FDA-APPROVED ADF LABELLED DRUG PRODUCTS:
- OxyContin (Vote)
- Embeda (Vote)
Additional Resources for Drug Formulary Commission meeting
Open PPTX file, 117.8 KB,
Meeting Presentation
(English, PPTX 117.8 KB)
Open DOCX file, 86.51 KB,
Meeting Presentation
(English, DOCX 86.51 KB)